Products 862109-64-6

CAS 862109-64-6 appears in our catalog under these names: 16α-hydroxy-3-oxo-lanosta-7,9(11),24-trien-21-oic acid, ≥95%, ≥95%, 16R-Hydroxy-3-oxolanosta7,9(11),24-trien-21-oic acid. Offered by: Chemat, MedChemExpress. Available pack sizes: 5mg, 25mg, 10mg.

16α-hydroxy-3-oxo-lanosta-7,9(11),24-trien-21-oic acid, ≥95%, ≥95%
Chemat
  • size: 5mg
  • Variants: 1
from 3021.20
View product
16R-Hydroxy-3-oxolanosta7,9(11),24-trien-21-oic acid
MedChemExpress
  • size: 25mg, 5mg, 10mg
  • Variants: 3
View product
Structural formula: {0} (CAS {1})

(2R)-2-[(5R,10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid (CAS 862109-64-6) is a chemical compound with the molecular formula C30H44O4 and a molecular weight of 468.7 g/mol. IUPAC name: (2R)-2-[(5R,10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid. InChIKey: LVYOXPQJURJWPC-MVQHSHHOSA-N.

Identity
Molecular formulaC30H44O4
Molecular weight468.7 g/mol
IUPAC name(2R)-2-[(5R,10S,13R,14R,16R,17R)-16-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-6-methylhept-5-enoic acid
InChIKeyLVYOXPQJURJWPC-MVQHSHHOSA-N
SMILESCC(=CCC[C@H]([C@H]1[C@@H](C[C@@]2([C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CCC(=O)C4(C)C)C)C)C)O)C(=O)O)C

Computed by PubChem (NCBI)

Synonyms: 16R-Hydroxy-3-oxolanosta7,9(11),24-trien-21-oic acid, 16alpha-Hydroxy-3-oxo-lanosta-7,9(11),24-trien-21-oic acid, 16|A-hydroxy-3-oxo-lanosta-7,9(11),24-trien-21-oic acid, orb1984405, 3-oxo-16alpha-hydroxy-lanosta-7,9(11),24-trien-21-oic acid, 3-oxo-16alpha-hydroxylanosta-7,9(11),24-trien-21-oic acid
Isomers (same molecular formula)
(2S,4aS,6aR,6aS,6bR,8aR,12aS,14bR)-2,4a,6a,6b,9,9,12a-heptamethyl-10,13-dioxo-1,3,4,5,6,6a,7,8,8a,11,12,14b-dodecahydropicene-2-carboxylic acid C30H44O4
3-[(1S,4R,5R,8S,9S,12S,13R)-4,8-dimethyl-5-[(1S)-1-[(2R)-5-methyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-12-prop-1-en-2-yl-13-tetracyclo[7.5.0.01,13.04,8]tetradecanyl]propanoic acid C30H44O4
(2S,4S,7S,8S,9S,12R,13R,16R,18R)-16-hydroxy-2,9,13,17,17-pentamethyl-7-(4-methylpent-3-enyl)-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-1(20)-ene-6,19-dione C30H44O4
(1S,2S,4S,5R,6S,11R,14R,15S,18S,23R)-6,10,10,14,15,21,21-heptamethyl-3,24-dioxaheptacyclo[16.5.2.01,15.02,4.05,14.06,11.018,23]pentacosane-9,25-dione C30H44O4
(E,6R)-6-[(5R,10S,13R,14R,15S,17R)-15-hydroxy-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid C30H44O4
(E,6R)-2-methyl-6-[(5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-3,7-dioxo-2,5,6,11,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-2-enoic acid C30H44O4
(2S,4S,7R,8S,9S,12R,13R,16S,18R)-16-hydroxy-2,9,13,17,17-pentamethyl-7-(4-methylpent-3-enyl)-5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icos-1(20)-ene-6,19-dione C30H44O4
(2S)-2-[1-[(1S,2S,5R,6S,9R,10R,13R,15S)-15-hydroxy-9,10,14,14-tetramethyl-16-oxapentacyclo[13.2.2.01,13.02,10.05,9]nonadecan-6-yl]ethenyl]-5-methyl-2,3-dihydropyran-6-one C30H44O4
(Z,6Z)-6-[(3aS,6S,7S,9aS,9bS)-6-(2-carboxyethyl)-3a,6,9b-trimethyl-7-prop-1-en-2-yl-2,4,7,8,9,9a-hexahydro-1H-cyclopenta[a]naphthalen-3-ylidene]-2-methylhept-2-enoic acid C30H44O4
(E,6R)-2-methyl-4-oxo-6-[(1S,3R,8R,11S,12S,15R,16R)-7,7,12,16-tetramethyl-6-oxo-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]hept-2-enoic acid C30H44O4
(1R,2R,5S,6R,9R,11S,14S,15R,19S,21R)-11-hydroxy-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.02,19.05,18.06,15.09,14]tetracos-17-ene-16,22-dione C30H44O4
(E)-6-[8-(2-carboxyethyl)-4a,8-dimethyl-1-methylidene-7-prop-1-en-2-yl-2,3,4,4b,5,6,7,9a-octahydrofluoren-2-yl]-2-methylhept-2-enoic acid C30H44O4